The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.

NCT04408937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Disease

Interventions

DRUG: triopifexor
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals